Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 568

1.

[Cardiac effects of hypertension].

Schmieder RE, Nitschmann S.

Internist (Berl). 2015 Apr 16. [Epub ahead of print] German. No abstract available.

PMID:
25874737
2.

Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies.

Böhm M, Schumacher H, Linz D, Reil JC, Ukena C, Lonn E, Teo K, Sliwa K, Schmieder RE, Sleight P, Yusuf S.

J Intern Med. 2015 Apr 15. doi: 10.1111/joim.12373. [Epub ahead of print]

PMID:
25872921
3.

Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.

Schmieder RE, Mitrovic V, Hengstenberg C.

Clin Res Cardiol. 2015 Mar 19. [Epub ahead of print]

PMID:
25787721
4.

New approaches in the treatment of hypertension.

Oparil S, Schmieder RE.

Circ Res. 2015 Mar 13;116(6):1074-95. doi: 10.1161/CIRCRESAHA.116.303603.

PMID:
25767291
5.

[Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology].

Vonend O, Böhm M, Eckert S, Hausberg M, Rittger H, Rump LC, Schmieder R, Schulte KL, Schunkert H, Uder M, Veelken R, Vorwerk D, Weil J, Wenzel U, Mahfoud F.

Dtsch Med Wochenschr. 2015 Mar;140(5):363. doi: 10.1055/s-0041-100835. Epub 2015 Mar 3. German.

PMID:
25734680
6.

Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension.

Pöss J, Ewen S, Schmieder RE, Muhler S, Vonend O, Ott C, Linz D, Geisel J, Rump LC, Schlaich M, Böhm M, Mahfoud F.

Clin Res Cardiol. 2015 Feb 26. [Epub ahead of print]

PMID:
25715938
7.

First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension.

Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G; GSR Investigators.

Hypertension. 2015 Apr;65(4):766-74. doi: 10.1161/HYPERTENSIONAHA.114.05010. Epub 2015 Feb 17.

PMID:
25691618
8.

Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial.

Lobo MD, Sobotka PA, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Ott C, Schmieder RE; for the ROX CONTROL HTN Investigators.

Lancet. 2015 Jan 22. pii: S0140-6736(14)62053-5. doi: 10.1016/S0140-6736(14)62053-5. [Epub ahead of print]

PMID:
25620016
9.

Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.

Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Ferreira AC, Pieper A, Kimmeskamp-Kirschbaum N, Bakris GL.

Am J Nephrol. 2014;40(6):572-81. doi: 10.1159/000371497. Epub 2015 Jan 10.

PMID:
25591469
10.

Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.

Böhm M, Schumacher H, Leong D, Mancia G, Unger T, Schmieder R, Custodis F, Diener HC, Laufs U, Lonn E, Sliwa K, Teo K, Fagard R, Redon J, Sleight P, Anderson C, O'Donnell M, Yusuf S.

Hypertension. 2015 Mar;65(3):651-61. doi: 10.1161/HYPERTENSIONAHA.114.04568. Epub 2015 Jan 12.

PMID:
25583157
11.

Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.

Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE.

Vasc Health Risk Manag. 2014 Dec 17;11:1-8. doi: 10.2147/VHRM.S75380. eCollection 2015.

12.

Wilder's principle: pre-treatment value determines post-treatment response.

Messerli FH, Bangalore S, Schmieder RE.

Eur Heart J. 2015 Mar 1;36(9):576-9. doi: 10.1093/eurheartj/ehu467. Epub 2014 Dec 23. Review. No abstract available.

PMID:
25540187
13.

Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.

Raff U, Walker S, Ott C, Schneider MP, Schmieder RE.

J Clin Hypertens (Greenwich). 2015 Feb;17(2):98-104. doi: 10.1111/jch.12458. Epub 2014 Dec 24.

PMID:
25537177
14.

Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.

Böhm M, Schumacher H, Schmieder RE, Mann JF, Teo K, Lonn E, Sleight P, Mancia G, Linz D, Mahfoud F, Ukena C, Sliwa K, Bakris G, Yusuf S.

J Intern Med. 2014 Nov 27. doi: 10.1111/joim.12333. [Epub ahead of print]

PMID:
25431275
15.

Aldosterone antagonists and renal denervation: friends or foes?

Mahfoud F, Ruilope LM, Böhm M, Schmieder RE.

Hypertension. 2015 Feb;65(2):280-2. doi: 10.1161/HYPERTENSIONAHA.114.04119. Epub 2014 Nov 24. No abstract available.

PMID:
25421977
16.

Species-specific viromes in the ancestral holobiont Hydra.

Grasis JA, Lachnit T, Anton-Erxleben F, Lim YW, Schmieder R, Fraune S, Franzenburg S, Insua S, Machado G, Haynes M, Little M, Kimble R, Rosenstiel P, Rohwer FL, Bosch TC.

PLoS One. 2014 Oct 24;9(10):e109952. doi: 10.1371/journal.pone.0109952. eCollection 2014.

17.

Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension.

Ewen S, Ukena C, Linz D, Kindermann I, Cremers B, Laufs U, Wagenpfeil S, Schmieder RE, Böhm M, Mahfoud F.

Hypertension. 2015 Jan;65(1):193-9. doi: 10.1161/HYPERTENSIONAHA.114.04336. Epub 2014 Oct 20.

PMID:
25331843
18.

1-Year outcomes of hypertension management in 13,000 outpatients under practice conditions: prospective 3A registry.

Zeymer U, Dechend R, Riemer T, Kaiser E, Senges J, Pittrow D, Schmieder RE; 3A Registry Investigators.

Int J Cardiol. 2014 Oct 20;176(3):589-94. doi: 10.1016/j.ijcard.2014.07.089. Epub 2014 Aug 1.

PMID:
25305705
19.

Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes.

Raff U, Ott C, Ruilope LM, Menne J, Haller H, Schmieder RE.

J Hypertens. 2014 Nov;32(11):2267-76; discussion 2276. doi: 10.1097/HJH.0000000000000313.

PMID:
25275251
20.

The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry.

Friedrich S, Zeymer U, Dechend R, Hagedorn I, Riemer T, Zemmrich C, Bramlage P, Pittrow D, Senges J, Schmieder RE.

J Hum Hypertens. 2015 May;29(5):316-23. doi: 10.1038/jhh.2014.86. Epub 2014 Oct 2.

PMID:
25273857
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk